ANALISIS KESESUAIAN BIAYA RIIL PADA PASIEN RAWAT INAP PENYAKIT GINJAL KRONIK DENGAN HEMODIALISIS DI RSUD DR. MOEWARDI SURAKARTA DENGAN INA-CBG’s TAHUN 2017

ASTUTI N, ASTUTI N (2018) ANALISIS KESESUAIAN BIAYA RIIL PADA PASIEN RAWAT INAP PENYAKIT GINJAL KRONIK DENGAN HEMODIALISIS DI RSUD DR. MOEWARDI SURAKARTA DENGAN INA-CBG’s TAHUN 2017. Tesis thesis, Universitas Setia Budi Surakarta.

[img] Text
INTISARI.pdf

Download (303kB)
[img] Text
TESIS FIX AMIN!!.pdf

Download (2MB)

Abstract

Patients with Chronic Kidney Disease is increasing from year to year and the average patient of Chronic Kidney Disease already in stage IV to V so that almost all patients of stage IV and V should do hemodialysis, it becomes a big problem because the cost during treatment is expensive, then done research of cost analysis. This study was aimed to determine the average of real cost, affect of the factors to real cost and fitness of real cost with INA-CBG's cost. This research was observational research using cross sectional research design according to hospital perspective. The subjects and the objects of this study were inpatient of chronic kidney disease stage IV and stage V who perform hemodialysis in DR. Moewardi Hospital period from January to December 2017. The data taken by retrospectively method and the data was quantitative data. The analysis used was One sample t-test. Based on the result obtained conclusions that the most used treatment of patients was anti-hypertension with furosemide drug of 8.66%, average of real cost based on grade and severity code of INA-CBG's N-4-10-I treatment class 1,2,3 were IDR. 7.450.946,50; IDR. 3.412.328,60; IDR. 1.970.663,43.. On the severity code of INA-CBGs N-4-10-II treatment class 1,2,3 were IDR. 10.473.257,00; IDR. 8.620.462,00; IDR. 3.894.940,70.. On the severity code of INA-CBGs N-4-10-III treatment class 1,2,3 were IDR. 15.934.157,94; IDR. 9.517.608,44; IDR. 8.974.199,00. The most influence factor was LOS (length of stay) with P value <0,05 (0,000). Statistical test results with a value of P <0.05 (0,000) real costs and INA-CBG's there is a discrepancy between the real costs and the INA-CBG's cost. Key words: Chronic Kidney Disease, Hemodialysis, Inpatient, Tarif INACBG’s, Analysis real Costs.

Item Type: Thesis (Tesis)
Uncontrolled Keywords: Chronic Kidney Disease, Hemodialysis, Inpatient, Tarif INACBG’s, Analysis real Costs.
Subjects: H Social Sciences > HG Finance
R Medicine > R Medicine (General)
Divisions: Fakultas Farmasi > Prodi S2 Farmasi
Depositing User: magdalena kartika ningsih
Date Deposited: 23 Feb 2019 04:26
Last Modified: 23 Feb 2019 04:26
URI: http://repository.setiabudi.ac.id/id/eprint/939

Actions (login required)

View Item View Item